Report: Surgery Protocols Work
Current protocols can prevent many wrong-site surgeries if they are properly followed, a Pennsylvania watchdog agency reports.
Print Issue: April 01, 2008
Agency to Consider Silodosin to Treat BPH
The FDA has accepted a New Drug Application for silodosin, a novel alpha1-adrenoreceptor antagonist, from Watson Pharmaceuticals, Inc., of Corona, Calif. Watson is seeking approval of silodosin for the treatment of BPH symptoms.
Blood-Thinning Drug Linked to Severe Allergic Reactions
The FDA announced that Baxter Healthcare Corporation, of Deerfield, Ill., has temporarily stopped manufacturing multiple-dose vials of heparin due to reports of severe allergic reactions and hypotension in patients who receive high “bolus” doses of the drug.
Filing for New Anemia Treatment in CKD Patients Accepted
AMAG Pharmaceuticals, Inc., of Cambridge, Mass., has announced that the FDA has accepted for standard review its New Drug Application (NDA) for ferumoxytol as an IV treatment of iron deficiency anemia in CKD patients.
Single-Pill Combo to Manage High Cholesterol Approved
Simcor (Niaspan/simvastatin), the first fixed-dose combination of two widely prescribed cholesterol therapies, has been approved for use along with diet to lower levels of elevated total cholesterol, LDL cholesterol, and triglycerides, and to raise HDL cholesterol in patients with complex lipid disease when treatment with monotherapies are not considered adequate.
Enteric-Coated Mycophenolate Sodium for Lupus Nephritis
Enteric-coated mycophenolate sodium is effective and well-tolerated in patients with active lupus nephritis, Hong Kong researchers report.
Renal Graft Survival Similar in Elderly, Younger Patients
Renal transplant recipients have similar death-censored graft survival regardless of age, according to researchers in Norway.
Repeat PSA Tests May Aid Prostate Biopsy Decisions
Following an initial PSA test result of 3.0-19.99 ng/mL in men aged 50-70 years, a repeat PSA test within seven weeks allows for more accurate assessment as to whether a biopsy will reveal prostate cancer, a British team reports.
Urologist Sued by Patient Mum about His Diabetes
Dr. U, 41, was a sole urologist in a small community in the Midwest. He’d been in private practice for only two years, but he felt quite positive about his professional prospects and his future—until he was sued.
Oxalobacter formigenes May Lower Stone Risk
Colonization with Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones, a study suggests.
- Loading...
Loading...
Loading... 
Loading...